FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies. [electronic resource]
Producer: 20161107Description: 44254-73 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Animals
- Area Under Curve
- Astrocytes -- drug effects
- Biomarkers, Tumor -- genetics
- Brain Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Cell Line, Tumor
- Cytokine TWEAK
- Female
- Humans
- Immunohistochemistry
- Likelihood Functions
- Membrane Glycoproteins -- genetics
- Mice, Nude
- Middle Aged
- Precision Medicine
- Predictive Value of Tests
- Prognosis
- ROC Curve
- Receptors, Tumor Necrosis Factor -- genetics
- Risk Assessment
- Risk Factors
- Spain
- TWEAK Receptor
- Thalidomide -- therapeutic use
- Tissue Array Analysis
- Tumor Microenvironment
- Tumor Necrosis Factors -- metabolism
- Xenograft Model Antitumor Assays
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.